Veronica Berry is Founder & Chief Executive Officer of TruDiary, an AI powered Prenatal Risk Assessment and Monitoring platform designed to reduce complications during pregnancy. Ms. Berry started the company in 2018, bringing more than 15 years of direct business, pharmaceutical and medical sales, marketing expertise, and executive management experience to lead the venture’s strategy, sales, marketing, and fundraising. In 2019, she was a winner in the Black Women Talk Tech and SXSW Pitch Black pitch competitions. She has also been featured in publications including Hypepotamus, Essence.com, Forbes, and Georgia Tech’s Advanced Technology Development Center newsletter. Berry is a member of Georgia Tech ATDC for entrepreneurs, Startup Health, NexCubed Digital Health, and Google For Startups Founders Academy. Before starting her entrepreneurial journey, she graduated from the University of Nebraska at Omaha, earning her bachelor’s degree in Communications and a Master of Public Policy from Clark Atlanta University. She continues to support UNO and Clark Atlanta, through donations to support student entrepreneurs.
A lack of access to appropriate care, patient information gaps, and poor patient engagement put women at an increased risk for negative maternal outcomes. TruDiary is a Prenatal Risk Assessment and Monitoring platform that makes prenatal care easier and more effective. The company is using AI technology to identify the probability of pregnancy complications, promote timely interventions, help prevent acute health events, and reduce the total cost of care. As patients monitor and record personal health information, the Algorithm creates, refines, and stratifies “health risk profiles” based upon three risk categories: normal, at risk, and high risk. If symptoms fall outside of defined parameters, the TruDiary app rates the risk category and alerts a patient’s care community. By referencing patient profiles and associated risk scoring, clinicians are provided access to information to improve individual care plans, reducing risk. The company’s goal is to create an increased path to full-term births in America, reducing maternal mortality, increasing the overall health of mothers, and shrinking the $26 billion that is associated with complicated pregnancies.